• 1
    Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275:964967.
  • 2
    Asahara T, Masuda H, Takahashi T et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85:221228.
  • 3
    Tateishi-Yuyama E, Matsubara H, Murohara T et al. Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bone-marrow cells: A pilot study and a randomized control trial. Lancet 2002; 360:427435.
  • 4
    Kobayashi T, Hamano K, Li TS et al. Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. J Surg Res 2000; 89:189195.
  • 5
    Andreeff M, Welte K. Hematopoietic colony-stimulating factors. Semin Oncol 1989; 16:211229.
  • 6
    Tsuchiya M, Nomura H, Asano S et al. Characterization of recombination human granulocyte-colony stimulating factor produced in mouse cells. EMBO J 1987; 6:611616.
  • 7
    Teshima T, Harada M, Takamatsu Y et al. Granulocyte colony-stimulating factor (G-CSF)-induced mobilization of circulating haematopoietic stem cells. Br J Haematol 1993; 84:570573.
  • 8
    Schwartzberg LS, Birch R, Hazelton B et al. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor. J Haemathother 1992; 1:317327.
  • 9
    Kang HJ, Kim HS, Zhang SY et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: The MAGIC cell randomised clinical trial. Lancet 2004; 363:751756.
  • 10
    Ripa RS, Yongzhong W, Jørgensen E et al. Bone-marrow stem cell mobilization induced by granulocyte-colony stimulating factor in patients with a PCI-treated acute ST-elevated myocardial infarction is safe: Results from a double-blind randomized study, the stem cells in myocardial infarction. (STEMMI) trial (Abstract). Circulation 2004; 110(suppl 3:238.
  • 11
    Pezsch M, Ince H, Kleine HD et al. No restenosis after G-CSF in acute myocardial infarction: Insights from FIRSTLINE-AMI (front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by granulocyte colony-stimulating factor) (Abstract). Circulation 2004; 110(suppl 3:238.
  • 12
    Ince H, Petzsch M, Kleine HD et al. Prevention of LV remodeling with G-CSF in acute myocardial infarction: Insights from FIRSTLINE-AMI (front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by granulocyte colony-stimulating factor) (Abstract). Circulation 2004; 110(suppl 3:352.
  • 13
    Minamino K, Adachi Y, Okigaki M et al. Macrophage colony-stimulating factor (M-CSF) as well as granulocyte colony-stimulating factor (G-CSF) accelerates neovascularization. Stem Cells 2005; 23:347354.
  • 14
    Petit I, Szyper-Kravitz M, Nagler A et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002; 3:687694.
  • 15
    Amano K, Okigaki M, Adachi Y et al. Mechanism for IL-1 beta-mediated neovascularization unmasked by IL-1 beta knock-out mice. J Mol Cell Cardiol 2004; 36:469480.
  • 16
    Iwasaki M, Adachi Y, Minamino K et al. Mobilization of bone marrow cells by G-CSF rescues mice from cisplatin-induced renal failure, and M-CSF enhances the effects of G-CSF. J Am Soc Nephrol 2005; 16:658666.
  • 17
    Shahin R, David L. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003; 9:702712.
  • 18
    Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267:1093110934.
  • 19
    Schaper W, De Brabander M, Lewi P. DNA synthesis and mitoses in coronary collateral vessels of the dog. Circ Res 1971; 28:671679.
  • 20
    Lindemann A, Rumberger B. Vascular complications in patients treated with granulocyte colony-stimulating factor (G-CSF). Eur J Cancer 1993; 29A:23382339.
  • 21
    Adachi K, Suzuki M, Sugimoto T et al. Effects of granulocyte colony-stimulating factor (G-CSF) on bleomycin-induced lung injury of varying severity. Toxicol Pathol 2003; 31:665673.
  • 22
    Takahashi T, Kalka C, Masuda H et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5:434438.
  • 23
    Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 2002; 20:43684380.
  • 24
    Detmar M, Yeo KT, Nagy JA et al. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol 1995; 105:4450.
  • 25
    Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13:1832.
  • 26
    Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18:425.
  • 27
    Thomas KA. Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 1996; 271:603606.
  • 28
    Barbera-Guillem E, Nyhus JK, Wolford CC et al. Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. Cancer Res 2002; 62:70427049.
  • 29
    Jablonska E, Puzewska W, Grabowska Z et al. VEGF, IL-18 and NO production by neutrophils and their serum levels in patients with oral cavity cancer. Cytokine 2005; 30:9399.
  • 30
    Asahara T, Takahashi T, Masuda H et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18:39643972.
  • 31
    Strehlow K, Werner N, Berweiler J et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003; 107:30593065.
  • 32
    Vajanto I, Rissanen TT, Rutanen J et al. Evaluation of angiogenesis and side effects in ischemic rabbit hind limbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ. J Gene Med 2002; 4:371380.